Companies
Zoetis
S&P 500Health Care· USA

ZTS

Status-Quo-Player

Zoetis

$120.08

+1.91%

Open $117.17·Prev $117.83

as of 13 Apr

STATUS-QUO-PLAYER

Power Core

The moat in one sentence: Zoetis's power derives from the compounding interaction between its direct-to-veterinarian sales network and a continuously refreshed product portfolio that creates switching costs at the point of prescribing, not at the point of chemistry.

Published1 Apr 2026
UniverseS&P 500
SectorHealth Care

Direction of Movement

Upward, Driven by Novel Biologics and Distribution Flywheel

ROC 200

-28.3%

Company Profile

Zoetis Inc. is a leading animal health company that engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health solutions. It operates across seven major product categories, including parasiticides, vaccines, dermatology, anti-infectives, pain and sedation, other pharmaceuticals, and animal health diagnostics. The company serves a diversified portfolio of species, encompassing livestock such as cattle, swine, poultry, fish, and sheep, as well as companion animals like dogs, cats, and horses. Zoetis Inc. holds the largest market share in the animal health industry, providing essential solutions for both production animals and pets worldwide. Its offerings support veterinarians, livestock producers, and pet owners by addressing key health needs in these sectors. Founded in 2013 and headquartered in Parsippany, New Jersey, Zoetis Inc. plays a pivotal role in advancing animal care through innovative products and services.

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Employees

14,500

This page is for informational purposes only and does not constitute investment advice. L17X Research is an independent research service.